Regulatory dysfunction refers to difficulties with self-regulation — managing sensory input, emotional arousal, and behavioral responses. Dr. Greenspan identified regulatory dysfunction as a distinct clinical profile that is often confused with autism but requires different treatment approaches. Children with regulatory dysfunction may have sensory sensitivities, attention difficulties, and emotional dysregulation without the core social-communicative differences of autism.
Dr. Greenspan argued that regulatory dysfunction requires treatment focused primarily on the sensory and regulatory system — working with the child’s Individual Differences to build self-regulation capacity. While Greenspan Floortime is beneficial for both autism and regulatory dysfunction, the emphasis differs: regulatory dysfunction treatment focuses heavily on sensory processing, arousal regulation, and building the child’s capacity for calm, focused engagement.
Dr. Greenspan was concerned that children with regulatory dysfunction were being incorrectly diagnosed with autism and given intervention plans that did not address their primary needs. Accurate diagnosis matters because regulatory dysfunction and autism, while they may co-occur, have different underlying profiles and benefit from different emphases in treatment.
Parents who suspect regulatory dysfunction should seek a comprehensive developmental evaluation that assesses sensory processing, motor functioning, and self-regulation capacity — not just behavioral checklists. A practitioner trained in the Greenspan/DIR Model can conduct this type of nuanced assessment and design an intervention that addresses the child’s actual Individual Differences profile.